Skip Navigation


Annals of Oncology Advance Access originally published online on March 5, 2008
Annals of Oncology 2008 19(5):1019-1020; doi:10.1093/annonc/mdn053
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/5/1019-a    most recent
mdn053v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Piedbois, P.
Right arrow Articles by Grenier, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Piedbois, P.
Right arrow Articles by Grenier, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letters to the editor

Reply to Letter to the editor, by Ishiguro et al. (Ann Oncol)

The first 10% of the full text of this article appears below.

Referring to our recent publication, Ishiguro and colleagues raise concerns about the use of pegfilgrastim 6 mg per cycle to support dose-dense (dd) chemotherapy. While we welcome debate, we would like to correct an inaccuracy in the interpretation of our study. The suggestion that hematological toxicity . . . [Full Text of this Article]

P. Piedbois1,*, D. Serin2, F. Priou3, P. Laplaige4, J.-F. Berdah5 and J. Grenier1

1 Department of Oncology, Hôpital Henri Mondor, Créteil, France
2 Department of Oncology, Institut Sainte Catherine, Avignon
3 Department of Oncology, Hôpital Départemental, La Roche Sur Yon
4 Department of Oncology, Clinique Saint-Come et Saint-Damien, Blois
5 Department of Oncology, Clinique de l'Espérance, Hyères, France

* (E-mail: pascal.piedbois@hmn.aphp.fr)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?